While FDA guidance (“Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices”) states that ...
UC Berkeley School of Public Health researchers are collaborating with the FDA and industry to make drug clinical trials ...
Please provide your email address to receive an email when new articles are posted on . Most patients supported the acceptability of an informed opt-out consent model for real-world data collection.
Clayton Irvine, PharmD, MBA, MS, explains that leveraging high-quality, real-world data; cross-institutional collaboration; standardized care pathways; advanced technologies; and integrated ...
The integration of real-world data (RWD) into protocol feasibility and site selection has emerged as a clinical trial game-changer in recent years. Traditionally relying heavily on data from carefully ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results